Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate and Prednisone for Systemic Vasculitis
NCT00001256Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 1990
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in granulomatosis with polyangiitis (GPA), polyarteritis nodosa (PAN), eosinophilic granulomatosis with polyangiitis (EGPA), microscopic polyangiitis (MPA), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 1990; status: completed.
02
Drugs
methotrexate
03
Conditions
granulomatosis with polyangiitis (GPA)polyarteritis nodosa (PAN)eosinophilic granulomatosis with polyangiitis (EGPA)microscopic polyangiitis (MPA)
Beyond the preview
Go deeper on NCT00001256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001256.